← Back to Screener
Merit Medical Systems Inc (MMSI)
Price$64.48
Value ScoreB
Growth ScoreB
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-33.46%
Price vs S&P 500 (4W)5.25%
VGM Score58.82
Market Capitalization$3.85B
P/E Ratio (Annual)29.94x
All Metrics
P/CF (Annual)12.94x
Book Value / Share (Quarterly)$27.27
P/TBV (Annual)4.99x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)9.61%
Cash Flow / Share (Quarterly)$3.64
Price vs S&P 500 (YTD)-35.00%
Gross Margin (TTM)48.69%
Net Profit Margin (TTM)9.03%
EPS (TTM)$2.32
10-Day Avg Trading Volume0.71M
EPS Excl Extra (TTM)$2.32
Revenue Growth (5Y)9.48%
EPS (Annual)$2.13
ROI (Annual)5.54%
Gross Margin (Annual)48.70%
Net Profit Margin (5Y Avg)7.17%
Cash / Share (Quarterly)$8.18
P/E Basic Excl Extra (TTM)27.61x
Revenue Growth QoQ (YoY)7.46%
EPS Growth (5Y)83.33%
P/E Normalized (Annual)29.94x
ROA (Last FY)4.78%
Revenue Growth TTM (YoY)11.10%
EBITD / Share (TTM)$5.19
ROE (5Y Avg)7.17%
Operating Margin (TTM)12.18%
Cash Flow / Share (Annual)$3.58
P/B Ratio2.36x
P/B Ratio (Quarterly)2.53x
Net Income / Employee (Annual)$17,100
EV / Revenue (TTM)2.65x
Net Interest Coverage (TTM)16.01x
ROA (TTM)5.25%
EPS Growth QoQ (YoY)38.84%
EV / EBITDA (TTM)13.11x
EPS Incl Extra (Annual)$2.13
Current Ratio (Annual)4.34x
Quick Ratio (Quarterly)3.31x
3-Month Avg Trading Volume0.78M
52-Week Price Return-32.28%
EV / Free Cash Flow (Annual)19.26x
P/E Incl Extra (TTM)27.61x
Revenue / Employee (TTM)$205,700
Tangible BV / Share (Quarterly)$18.69
P/S Ratio (Annual)2.54x
Asset Turnover (Annual)0.56x
52-Week High$96.74
Operating Margin (5Y Avg)9.36%
EPS Excl Extra (Annual)$2.13
CapEx CAGR (5Y)11.47%
Tangible BV CAGR (5Y)12.12%
26-Week Price Return-25.53%
Quick Ratio (Annual)2.80x
13-Week Price Return-12.26%
Total Debt / Equity (Annual)0.46x
Current Ratio (Quarterly)5.08x
Enterprise Value$4.09B
Revenue / Share Growth (5Y)7.58%
Asset Turnover (TTM)0.58x
Book Value / Share Growth (5Y)9.11%
Revenue / Employee (Annual)$202,100
Inventory Turnover (Annual)2.43x
Pretax Margin (Annual)11.28%
Cash / Share (Annual)$7.51
3-Month Return Std Dev34.60%
Gross Margin (5Y Avg)46.56%
Net Income / Employee (TTM)$18,600
EBITDA CAGR (5Y)27.19%
EBITDA Interim CAGR (5Y)15.96%
ROE (Last FY)8.11%
Net Interest Coverage (Annual)17.60x
EPS Basic Excl Extra (Annual)$2.13
P/FCF (TTM)17.69x
Receivables Turnover (TTM)7.60x
EV / Free Cash Flow (TTM)18.83x
Total Debt / Equity (Quarterly)0.45x
EPS Incl Extra (TTM)$2.32
Receivables Turnover (Annual)7.70x
ROI (TTM)6.08%
P/S Ratio (TTM)2.49x
Pretax Margin (5Y Avg)8.69%
Revenue / Share (Annual)$25.07
Tangible BV / Share (Annual)$17.61
Forward P/E15.04x
Free OCF CAGR (5Y)12.87%
Price vs S&P 500 (52W)-56.64%
P/E Ratio (TTM)27.61x
EPS Growth TTM (YoY)13.63%
Year-to-Date Return-26.84%
5-Day Price Return3.92%
EPS Normalized (Annual)$2.13
ROA (5Y Avg)4.25%
Net Profit Margin (Annual)8.48%
Month-to-Date Return2.25%
Cash Flow / Share (TTM)$3.21
EBITD / Share (Annual)$5.09
EPS Growth (3Y)18.07%
Operating Margin (Annual)12.19%
LT Debt / Equity (Annual)0.46x
P/CF (TTM)12.93x
ROI (5Y Avg)5.05%
P/E Excl Extra (TTM)27.61x
LT Debt / Equity (Quarterly)0.45x
EPS Basic Excl Extra (TTM)$2.32
P/TBV (Quarterly)3.69x
P/B Ratio (Annual)3.30x
Inventory Turnover (TTM)2.36x
Pretax Margin (TTM)12.09%
Book Value / Share (Annual)$26.66
Price vs S&P 500 (13W)-20.51%
Net Margin Growth (5Y)74.39%
Beta0.52x
P/FCF (Annual)18.10x
Revenue / Share (TTM)$25.70
ROE (TTM)8.95%
52-Week Low$59.74
vGradeB
gGradeB
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 260.94est. 0.85
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.22
4.22
4.22
4.18
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MMSIMerit Medical Systems Inc | B | B | C | $64.48 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
Merit Medical Systems develops and manufactures medical devices for interventional cardiology, radiology, and endoscopy procedures. The Cardiovascular segment generates the majority of revenue, encompassing cardiology and radiology products for treating coronary artery disease, peripheral vascular disease, and other conditions, including embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.